RxDoctor Payments Data

Yusuke Wakeshima, MD

Physical Medicine & Rehabilitation · Denver, CONPI 1215992474

Payments from drug & device makers

What this record shows

International Rehabilitative Sciences, Inc accounts for 66.4% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2024 at $3,465 and has fallen 85.6% since, to $500 in 2025. Among physical medicine & rehabilitation clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,365in general payments, 2019–2025

Across 95 payments — averaging $56.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • International Rehabilitative Sciences, Inc$4K
  • Boston Scientific$505
  • Scilex Pharmaceuticals Inc.$309
  • Lilly USA, LLC$241
  • Zyla Life Sciences, Inc.$163
  • Abbott$98
  • plus $484 from 15 others

What the payments were for

  • Food & beverage$2,42045%
  • Other$2,94555%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,365 in reported general payments places this provider in the 90th percentile of 199 physical medicine & rehabilitation providers in Colorado.

See all physical medicine & rehabilitation providers in Colorado

Medicare billing

Part B allowed, 2024
$7,382
Medicare patients
12
Services billed
67

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Buprenorphine11$1,551
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen32$778
Oxycodone Hcl62$589
Morphine Sulfate ErMorphine Sulfate26$470
Gabapentin51$403
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen15$253
Tramadol Hcl18$45

Paid to pharmacies, not to this prescriber.

Other physical medicine & rehabilitation in Denver

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →